These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19652769)

  • 1. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".
    Zimmermann US; Winkelmann PR; Pilhatsch M; Nees JA; Spanagel R; Schulz K
    Dtsch Arztebl Int; 2009 Jul; 106(27):464-7. PubMed ID: 19652769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan withdrawal and dependence syndrome.
    Mutschler J; Koopmann A; Grosshans M; Hermann D; Mann K; Kiefer F
    Dtsch Arztebl Int; 2010 Jul; 107(30):537-40. PubMed ID: 20737060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three cases of "spice" exposure.
    Simmons J; Cookman L; Kang C; Skinner C
    Clin Toxicol (Phila); 2011 Jun; 49(5):431-3. PubMed ID: 21740143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
    Järbe TUC; Raghav JG
    Curr Top Behav Neurosci; 2017; 32():263-281. PubMed ID: 27753006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spice drugs as a new trend: mode of action, identification and legislation.
    Vardakou I; Pistos C; Spiliopoulou Ch
    Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey study to characterize use of Spice products (synthetic cannabinoids).
    Vandrey R; Dunn KE; Fry JA; Girling ER
    Drug Alcohol Depend; 2012 Jan; 120(1-3):238-41. PubMed ID: 21835562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spice drugs: cannabinoids as a new designer drugs].
    Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
    Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond THC: The New Generation of Cannabinoid Designer Drugs.
    Fattore L; Fratta W
    Front Behav Neurosci; 2011; 5():60. PubMed ID: 22007163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of cannabis tolerance and dependence.
    Jones RT; Benowitz NL; Herning RI
    J Clin Pharmacol; 1981; 21(S1):143S-152S. PubMed ID: 6271820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    Lam PW; Frost DW
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregabalin Dependence: A Case Report].
    Aldemir E; Altıntoprak AE; Coşkunol H
    Turk Psikiyatri Derg; 2015; 26(3):217-20. PubMed ID: 26364177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine dependence and withdrawal: a case report.
    Yargic I; Caferov C
    Subst Abus; 2011 Jul; 32(3):168-9. PubMed ID: 21660879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.
    Cooper ZD
    Curr Psychiatry Rep; 2016 May; 18(5):52. PubMed ID: 27074934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?
    Hughes JR; Oliveto AH; Helzer JE; Higgins ST; Bickel WK
    Am J Psychiatry; 1992 Jan; 149(1):33-40. PubMed ID: 1728182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spice: a new "legal" herbal mixture abused by young active duty military personnel.
    Bebarta VS; Ramirez S; Varney SM
    Subst Abus; 2012; 33(2):191-4. PubMed ID: 22489593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driving under the influence of synthetic cannabinoids ("Spice"): a case series.
    Musshoff F; Madea B; Kernbach-Wighton G; Bicker W; Kneisel S; Hutter M; Auwärter V
    Int J Legal Med; 2014 Jan; 128(1):59-64. PubMed ID: 23636569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.